Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
NCI-2015-00863
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Adult (18-64)
Older adult (65+)
NCI-2020-06381
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Adult (18-64)
Older adult (65+)
NCI-2022-01540
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Cancer
Adult (18-64)
Older adult (65+)
S1803
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Adult (18-64)
Older adult (65+)
A211901
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Adult (18-64)
Older adult (65+)
S2104
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Adult (18-64)
Older adult (65+)
NCI-2023-09270
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Adult (18-64)
Older adult (65+)
NRG-BN011
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Adult (18-64)
Older adult (65+)
NCI-2023-08628
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Older adult (65+)
A042001
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma
Adult (18-64)
Older adult (65+)